Registry-listed formulations

Nepadutant · chembl:CHEMBL1908318

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

4 source entries across 2 studies. This list may not include all unresolved or historical entries.

Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
100%(3 trials)

Phase Distribution

Phase 1
1
25%
Phase 2
3
75%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 23 (75.0%)

Trials by Status

completed375%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_2

Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

NCT01532518
completedphase_2

Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic

NCT01258153
withdrawnphase_2

Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment

NCT01309009
completedphase_1

A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants

NCT00655083

Clinical Trials (4)

Showing 4 of 4 trials
NCT01532518Phase 2

Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

Completed
NCT01258153Phase 2

Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic

Completed
NCT01309009Phase 2

Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional Treatment

Withdrawn
NCT00655083Phase 1

A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants

Completed

All 4 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Protein
Total Trials
4

External References

ChEMBL
CHEMBL1908318